Vimicin Biosciences completes over 100 million yuan Series D+ financing deal.

On July 21st, Weimou Biotechnology Co., Ltd. announced the completion of over 100 million RMB in Series D2+ financing. This round of funding was led by Ouhai Xiangtou Village Equity Investment Partnership Enterprise, with follow-on investments from Guangdong Science Finance, Renzhe Zhenhe, and other new investors. Existing shareholders Longpan Investment and Yicun Capital continued to increase their support.